Repare Therapeutics @RepareRx
Repare is a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development of novel therapeutics. reparerx.com Montréal, Québec Joined June 2017-
Tweets163
-
Followers1K
-
Following5
-
Likes15
We are thrilled the first patient has been dosed with the first combination of PKMYT1i + WEE1i to enter the clinic. We are grateful to collaborate with @DebiopharmNews in this shared mission to deliver innovative precision medicine therapies to patients. lnkd.in/enqBacnx
Meet with @RepareRx's management team at the 2024 @bloomburton Healthcare Investor Conference on Tuesday for 1x1s and a company presentation. We look forward to connecting in person! Webcast can be found here: lnkd.in/eyepZbQJ #BBHIC2024 #syntheticlethality $RPTX
Please join us at a Major Symposium Session at the #AACR24 Annual Meeting on lunresertib and combinations with ATR or WEE1 inhibitors “Targeting CDK1 Activation in Cancer”, presented by Jordan Young, Senior Director, Oncology Discovery at @RepareRx. #syntheticlethality $RPTX
That's a wrap with the @TDCowen 44th Annual Health Care Conference in which Repare's EVP & Chief Medical Officer, Maria Koehler MD PhD, spoke as a panelist on the Gynecological Cancers Panel. Thank you for listening: lnkd.in/gZVwWjmC #TDCowenHealthCare #precisiononcology
We announced Q4 & FY 2023 financial results and provided a business update. As leaders and innovators in #PKMYT1 inhibition, we look forward to data readouts across all ongoing lunresertib trials in 2024 and begin a combo trial with @DebiopharmNews. lnkd.in/eKTV-FRr $RPTX
Don't miss Ale's presentation on Saturday at the 6th DNA Repair/Replication Structures and Cancer Conference. He is speaking about the power of #syntheticlethality, after Dr. Timothy Yap's presentation on Targeting ATR in the Clinic. #DRRSC24
We are proud to announce first patient dosing in our Ph1 LIONS #clinicaltrial of RP-1664, a potential first-in-class, oral PLK4 inhibitor, designed to harness the #syntheticlethal relationship with TRIM37 amplification or O/E in #solidtumors. lnkd.in/eSsZkAGa $RPTX
At Repare we’re committed to discovering and developing highly targeted #cancertherapies for patients. With #WorldCancerDay approaching, we recognize and support the global community in the mission to #CloseTheCareGap to create easier access to vital cancer services. #FightCancer
"If you want to go far, go together." We celebrated the beginning of our clinical collaboration with @DebiopharmNews at #JPM2024 this week. This partnership accelerates our shared mission to transform the landscape of cancer treatment and improve patient outcomes. #PKMYT1 #WEE1
Today, we provided a corporate update and highlighted key anticipated milestones. 2024 will be a substantial year for Repare as we aim to expand our pipeline to four clinical programs and expect multiple readouts from ongoing lunresertib combinations. lnkd.in/e59RZrBh
Today, Repare disclosed the target of the RP-1664 development program and reported comprehensive preclinical data for RP-1664 and RP-3467. We’re hosting a conference call & webcast at 8 a.m. ET today to discuss the data. Full press release: bit.ly/47yXGGp
Tomorrow, we're hosting a conference call and webcast call focused on our emerging late-stage pipeline programs, RP-1664 and RP-3467. Tune in here at 8am ET: bit.ly/3FPVOxj
Join us tomorrow at the @Stifel 2023 Healthcare Conference, where members of Repare’s management team will participate in a fireside chat. Watch the webcast here: bit.ly/3ugACxD
Today, we announced our third quarter 2023 financial results and provided a business update. Full press release with additional details: bit.ly/49qKl4L #precisiononcology #syntheticlethality $RPTX
Next Wednesday (11/15), Repare will host a conference call and webcast to present the latest data from its ongoing preclinical programs, RP-1664 and RP-3467, a newly designated Polθ inhibitor. Tune in here: bit.ly/49pOxBB
Members of Repare’s management team will participate in the @Stifel 2023 Healthcare Conference and the @Piper_Sandler 35th Annual Healthcare Conference this month. We look forward to connecting in person! Webcasts can be found here: bit.ly/3FMGmSr
Daniel Durocher @durocher1
4K Followers 907 Following Lunenfeld-Tanenbaum Research Institute & U of Toronto // Lab tweets @durocherlab // Founder of @RepareRx // DNA repair, Synthetic lethality, Induced proximity
Stephanie Panier @spanier55
944 Followers 559 Following Group Leader at Max Planck Institute for Biology of Ageing and at the University of Cologne. Studying how cells repair DNA damage.
Agnel Sfeir @AgnelSfeir
2K Followers 395 Following Scientist during the day. Rock climber, scuba diving, sky diving during off hours. Prof. @MSKCC and co-founder of @RPTX. 🇱🇧+🇺🇸 in NYC
Alberto Ciccia @CicciaAlberto
2K Followers 1K Following Scientist at Columbia University interested in genome stability and genome editing | https://t.co/eX2AJeJQtL
durocherlab @durocherlab
3K Followers 2K Following We are located at the Lunenfeld-Tanenbaum Research Institute and work on understanding the fascinating processes underlying genome integrity
Jacob Corn @jcornlab
5K Followers 508 Following Genome editing, functional genomics, and cells figuring out how to eat themselves without dying. Professor of Genome Biology at ETH Zürich.
Dheva Setiaputra @biochemDheva
418 Followers 194 Following Assistant Professor at SFU | Molecular mechanisms of the DNA damage response | Enjoys long sits on the couch | Views + good jokes my own, bad jokes yours |
Sarah R. Hengel Ph.D. @science_SRH
4K Followers 1K Following Human Being | She/her| Mother of 🐕 | 🌈 | Lyme Disease Survivor | Personal account | tik tok : sarahtheproteinscientist | opinions my own| rt means support
Tony Cesare @tonycesare4
543 Followers 673 Following Researcher studying genome stability. Head coach Wests Boomers U14 and U10 Baseball. Views are my own. For lab news see @TheCesareLab.
Robert W. Sobol @rwsobol
3K Followers 5K Following Dean’s Professor of Cancer Research & Associate Director Basic Research; Legorreta Cancer Center, Brown University - studying DNA damage response in cancer
Patrick Hsu @pdhsu
30K Followers 3K Following co-founder @ArcInstitute, @BerkeleyBioE professor | researcher & investor in genome editing, biotech, AI | 🇨🇦 @harvard @broadinstitute @editasmed, Fast Grants
michele pagano @paganolab
2K Followers 910 Following Studying the molecular mechanisms underlying the degradation of cellular regulatory proteins by the ubiquitin system and inform about cancer vulnerabilities
Arne N. Kousholt @ArneKousholt
456 Followers 770 Following CEO and Founder, VUS Dx. Functional assays to help guide personalised treatment for cancer patients. DNA repair. CRISPR. Acquired drug resistance.
Haico van Attikum @ha.. @haicovanattikum
2K Followers 698 Following Full professor at Leiden University Medical Center. Studying DNA repair in chromatin and its link to human disease.
Ben Kleinstiver @BKleinstiver
4K Followers 670 Following Associate Professor @CGM_MGH at @MGH_RI & @HarvardMed Genome editing / Protein eng. / Molecular medicine 🇨🇦🧬 Kayden-Lambert MGH Research Scholar '23-28
Sharon B. Cantor @CantorLab
2K Followers 834 Following Professor studying DNA replication and role in cancer, chemoresistance, and developmental diseases
Pierre Caron @CaronPierre13
1K Followers 3K Following @IBS_Grenoble @IRIG_Grenoble @cea_grenoble | CNRS researcher | @Prelights | @EDRA_Webinars
Amisha @amishaminju
78 Followers 1K Following PhD Student Department of Human Genetics McGill University
DSI, a PLG Company @DSInPharmatics
314 Followers 1K Following DSI is a full service CMC Drug Development Consulting Firm, assisting emerging Biotech and Pharma sponsors with CMC, Regulatory and QA for NCEs & Biologics
Alex @AlexAtYUL
6 Followers 5 Following
David Krochmal @solarenergydave
8 Followers 50 Following Energy Consultant Solar Dave, LLC Solar energy for businesses and residential properties.
Eric Chih-Chao Liang @EricCCLiang
110 Followers 265 Following Research Scientist | Biochemist and Structural Biologist | PostDoc at @TheCrick | DNA Repair & Recombination | PhD from @UniofOxford
Tammy Kapur @KapurTammy
0 Followers 7 Following
Cancer Research Horiz.. @CR_Horizons
2K Followers 2K Following We are @CR_UK’s #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
Thorben Huth @ThorbenGorm
42 Followers 236 Following Postdoc at UKHD | Biochemist and Cancer Scientist | CRISPR Aficionado | Outdoor Lover and Scout
kavita_gala @KavitaGala
369 Followers 404 Following
Jonathan Lee @ColdCasanova1
39 Followers 286 Following
Priya Chudasama @priyachudasama5
551 Followers 208 Following Translational sarcoma researcher @NCT_HD and @DKFZ. Interested in functional and structural genomics in sarcoma, mentoring, mountain hikes and food.
Stavroula Tsaridou @Stavroula_Tsar
77 Followers 289 Following PhD student of the Medical Oncology Department of @UMCG studying DNA damage responses. 🧬🔬
Megan E. Kelley, PhD @MeganEKelley
746 Followers 2K Following Postdoc @MSKCancerCenter in https://t.co/FldT6CqBJG | former @KapoorLab_RU | interested in #CancerBiology #DNARepair #DrugResistance #Mitosis | she/her
Tomas Goncalves @Tomas1Goncalves
19 Followers 44 Following DPhil student @MRC_WIMM in the Radcliffe Department of Medicine. MSci Human Genetics @UCL. I study how cancers maintain their telomeres to divide indefinitely
Jiajun Gu @GuJiajun714
30 Followers 18 Following
Benoit Larose🩺💉.. @blarose33
1K Followers 3K Following PDG BioQuébec. Voir mon profil LinkedIn has it all... https://t.co/nj5hqMqHRV
Jeff J. Grice @iamJ2GRICE
2K Followers 870 Following Head of Marketplace Ops | Startup Investor | Tesla & SpaceX Investor | Laguna Beach🛬Detroit #Tesla #SpaceX #AI #Housing #Tech #web3 🇺🇸
The Cancer Dependency.. @CancerDepMap
3K Followers 273 Following We construct systematic key datasets, analytical and visualization tools to accelerate precision cancer medicine #depmap #syntheticlethal #drugtargets
Cynthia bernier @CBY12T23
0 Followers 5 Following
Lenno Krenning @KrenningLenno
28 Followers 40 Following
Mohammad Daud @itsmudaud
96 Followers 401 Following Molecular Genetics @UofT current sciencegasm: gene editing, plant immunity, mtDNA quality control
Florin-Mihai Danciu @FlorinMihaiMik
213 Followers 649 Following
Madeleine King @madbking5
93 Followers 289 Following Ph.D. candidate in the @LapinaiteRNALab at Arizona State University | Precise Genome Editing, RNA Biologist, Protein Engineering, CRISPR-Cas9
Christopher Johnny @ChrisJScience
135 Followers 155 Following Harvard College '18 BA Chemistry, Chinese language citation// University of Pennsylvania '24 PhD Chemistry
The Jacobian Ghost @JacobianGhost
1 Followers 72 Following
Ksenia G. Kolobynina @KKolobynina
24 Followers 191 Following PhD student at Cardoso Lab, TU Darmstadt Science interests: DNA repair, DNA replication, chromatin, senescence
Nazareno Bona @NazarenoBona
221 Followers 256 Following Research Associate @Cambridge_Uni | Transposable elements 🧬 | College Research Associate @SidneySussex | Former PhD student @MRC_LMB
J @wardenofthewest
72 Followers 262 Following
Augusto Chaves Murrie.. @AugustoChavesM
20 Followers 58 Following Lab Manager in the Hamperl lab at @epigeneticsHMGU @HelmholtzMunich Former student at University of Buenos Aires Working on transcription replication conflicts
Dale Ramsden @dale_ramsden
392 Followers 354 Following interested in genome stability and end joining pathways for double strand break repair. @UNC, @UNC_Lineberger
Tom Watkins @tbkwatkins
986 Followers 3K Following Postdoc @mischellab | incoming PGY1 @StanfordPath Physician Scientist Incubator Track | visiting scientist @SwantonLab | @UCL_MBPhD alum
Annabel Quinet @AnnabelQuinet
619 Followers 460 Following Group Leader @INSERM @CEA_Jacob_ fascinated about the links between DNA replication, genome stability and cancer. Eclectic Brazilian carioca, mom
Dr B Ciani - https://.. @BCiani
572 Followers 946 Following Misplaced chemist doing biology. Dog lover. In Yorkshire fro Rome She/her. If I tweet, it's my own opinion. @[email protected];@drbciani.bsky.social
Lauren Evans @laur_tay_evs
218 Followers 181 Following A journey of a thousand miles must begin with a single step (she/her)
Darshika Bohra @SanskariMarwadi
185 Followers 348 Following Waddling through grad school one DNA damage at a time/🔬chromatin organization in context of damage/LLPS/Always up for an espresso and some good old running 🏃
Paul & Virginie - Cen.. @CentrioleLab
4K Followers 2K Following Paul Guichard & Virginie Hamel Lab @Biologie_UNIGE #cryoEM and #cryoET❄️ #UExM ⚗️ #cellbiology #TeamTomo @[email protected]
Catalina @Catalina12_10
2 Followers 41 Following
Hola @mostmodest2
409 Followers 3K Following
Ananya Acharya @AnanyaAcharya26
191 Followers 653 Following PhD @Cejkalab, Institute for Research in Biomedicine @Bellinzonairb, Department of Biology, ETH Zurich @ETH_DBIOL; BS-MS IISER Kolkata @iiserkol.
Marek Adamowicz @MarekAdamow
105 Followers 136 Following Research scientist working with BER/PARPs/Transcription/DSBs. Postdoc in @BoultonLab. PhD with @FdAdF66.
KJ Patel CAM-OX trave.. @ketanpatelimmo1
1K Followers 2K Following Aldehyde enthusiast in research and consumption
Luca Fava @LucaFava14
478 Followers 377 Following Team leader and associate professor at CIBIO, University of Trento. Interested in how cells sense and transduce malfunctions of the cell division cycle
Dr Hannah Bolland @onco_hannah
931 Followers 2K Following Cancer biologist, lover of tumour hypoxia, peroxisomes, unfolded protein response. Junior Group Leader/Surrey Future Fellow @UniOfSurrey @SurreyVet
おっと @GunFamily36
84 Followers 278 Following 妻 卵巣がん 漿液性ステージ3 BRCA陽性。情報収集アカウント。TC6クール後アバスチン+リムパーザ。ハイパーサーミア、高濃度ビタミンC、遺伝子治療、アルテミシニンなど併用。
Sidrit Uruci (Sid) @UruciSidrit
246 Followers 380 Following PhD in @luijsterburglab at @LUMC_Leiden, previously in @Tanejalab at @ErasmusMC. Science lover, DNA enthusiast. European child 🇪🇺🇳🇱🇮🇹🇦🇱🏳️🌈
Scott Keeney @Spo11Rulz
3K Followers 1K Following Scientist. Meiosis nerd. 🏳️🌈 Queer as a $3 bill. He/him. No birds were harmed in the making of these tweets. @[email protected]
Daniel Durocher @durocher1
4K Followers 907 Following Lunenfeld-Tanenbaum Research Institute & U of Toronto // Lab tweets @durocherlab // Founder of @RepareRx // DNA repair, Synthetic lethality, Induced proximity
Agnel Sfeir @AgnelSfeir
2K Followers 395 Following Scientist during the day. Rock climber, scuba diving, sky diving during off hours. Prof. @MSKCC and co-founder of @RPTX. 🇱🇧+🇺🇸 in NYC
durocherlab @durocherlab
3K Followers 2K Following We are located at the Lunenfeld-Tanenbaum Research Institute and work on understanding the fascinating processes underlying genome integrity
BIOTECanada @BIOTECanada
7K Followers 2K Following All about Canadian biotechnology from the national industry association.
Nasdaq Exchange @NasdaqExchange
762K Followers 8K Following At @Nasdaq, we power stronger economies, create more equitable opportunities, and contribute to a more sustainable world. #NasdaqListed@RepareRx See you at the Gold Leaf Awards on September 27th!
Exciting data today by Dr. Tim Yap + @RepareRx in #AACR2023 plenary session. Camonsertib, partnered with @Roche, continues to show high promise for patients with ovarian and other cancers. 👏Drs Maria Koehler, Mike Zinda and their teams! #precisiononcology #syntheticlethality
Today at #AACR23 Clinical Trials Plenary Session, Repare disclosed initial data from our ongoing Phase 1/2 TRESR and ATTACC clinical trials evaluating camonsertib in combination with three PARP inhibitors in patients with #solidtumors. Full presentation: tinyurl.com/ywvz72v4
Broad's @CancerDepMap Consortium, is entering a new phase, with 19 biopharma partners, and accelerating its research into tumor vulnerabilities and identifying key biomarkers. broad.io/DepMap-News-01…
We just finished a very successful lab retreat - the first one since the pre-pandemic times. It was great to be together for great science, nice dinner, chilly fire pit and some pretty good memes...
.@NasdaqExchange congratulates #NasdaqListed @RepareRx on its license and collaboration deal with @Roche. 🎉 The collaboration allows for the development of camonsertib (RP-3500) with potential to expand development into additional tumors and multiple combination studies.
Our work on the identification of the PKMYT1 kinase (aka Myt1) as a vulnerability in cyclin E gene-amplfied cells is (finally) published! nature.com/articles/s4158… [paper is OA]. This work was a close collaboration with @RepareRx 1/5
+1000000, one was my mom 💔
A day to remember the many wonderful women that lost the battle to breast cancer. And for those that are fighting today -> Keep strong. You´re not alone. BIG HUG. #worldbreastcancerday
Thanks, #NASDAQ for a reminder that a year has passed since @RepareRx IPO. 2 clinical programs and an incredible year of progress later by our amazing team, feels like the blink of an eye. #precisiononcology #syntheticlethality
This one means a lot to me as it is the first target we discovered through our screens for which we developed a drug that we bring to the clinic. Thank you to the patients in this study and crossing fingers and toes that we can make a difference! 🤞
We’re thrilled to have dosed the first patient in our Phase 1 RP-6306 trial! Click this link to read our full press release: ir.reparerx.com/news-releases/…
The second Repare drug enters the clinic. Congrats to the $RPTX @RepareRx team.
We’re thrilled to have dosed the first patient in our Phase 1 RP-6306 trial! Click this link to read our full press release: ir.reparerx.com/news-releases/…
Today, I am one proud @RepareRx team member. So happy for my friend @durocher1 , his baby will make a difference in CCNE high tumors. The brilliance of @MichaelZinda and Maria Koehler will make this happen. Kudos to @JTFYoung , David Gallo, Jimmy, Gary, and the rest of the team
New preprint from the @durocherlab ! In close collaboration with our colleagues at @RepareRx we report that inhibition of the kinase PKMYT1 is lethal in cells with cyclin E (CCNE1) gene amplification. biorxiv.org/content/10.110… 1/7
New preprint from the @durocherlab ! In close collaboration with our colleagues at @RepareRx we report that inhibition of the kinase PKMYT1 is lethal in cells with cyclin E (CCNE1) gene amplification. biorxiv.org/content/10.110… 1/7
Jobs for enthusiasts of science, data science and willing to make a dent (or a double-strand break) in cancer. Well funded and collaborating with top academic groups on genomics, synthetic lethality and CRISPR screens. @RepareRx lnkd.in/dpKEkXW lnkd.in/dMXDqcH
Proud of this initiative from my colleagues at @RepareRx in partnership with @nsbeboston ! A similar initiative is being set up in MTL too.
Repare Therapeutics partners with NSBE Boston to promote STEM Initiatives - mailchi.mp/nsbeboston/jb-…
Repare Therapeutics partners with NSBE Boston to promote STEM Initiatives - mailchi.mp/nsbeboston/jb-…
Trends for United States
You might like
